Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-027344

President and CEO sold 28,502 shares at an average $6.23 ($177,509)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-04 Sale : show line 1 in the form −633 $6.26 $3,963 661,317 D
2022-05-04 Sale : show line 2 in the form −27,869 $6.23 $173,546 633,448 D
Open-market sales · 28,502 sh · avg $6.23 · $177,509
Loading xslF345X03/doc4.xml…